| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | −5.7× | −10.3× | |
| Price / Book | 1.0× | 3.2× | |
| Price / Sales | 0.8× | 273.7× | |
| Price / Free cash flow | 5.7× | −25.6× | |
| EV / EBITDA | −36.0× | −20.9× | |
| Earnings yield | −17.6% | −5.2% | |
| Free cash flow yield | 17.7% | −3.9% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
BRNAS:BRVEBraveheart Bio Inc · 🇺🇸 NAS | $19.21 | +2.67% | $1.73B | −25.5× | −78.6% | — |
KRNAS:KRSAKorsana Biosciences Inc · 🇺🇸 NAS | $31.41 | −3.00% | $1.43B | −418.0× | −38.8% | +1266.2% |
CTNAS:CTYCITY THERAPEUTICS INC · 🇺🇸 NAS | $21.46 | −4.20% | $1.08B | −19.3× | 69.1% | — |
OBNAS:OBXObsidian Therapeutics Inc · 🇺🇸 NAS | $11.94 | +1.44% | $737.57M | 4.9× | 2,275.2% | — |
ATNAS:ATTOAttovia Therapeutics Inc · 🇺🇸 NAS | $13.89 | +1.17% | $634.1M | −10.3× | −40.4% | — |
BLNAS:BLSMBlossomHill Therapeutics Inc · 🇺🇸 NAS | $14.16 | +1.58% | $450.07M | −7.3× |
| 46.0% |
| — |
VONAS:VOGXVogenx Inc · 🇺🇸 NAS | $15.92 | +9.57% | $236.49M | −149.3× | 157.3% | — |
CNNAS:CNSYCerenome, Inc. · 🇺🇸 NAS | $1.65 | −2.94% | $12.52M | −0.6× | −560.2% | +150.0% |
EONAS:EOCNEocene Ltd. · 🇺🇸 NAS | $2.85 | +0.00% | $2.97M | −0.3× | −65.3% | +95.2% |
